NVX-CoV2373 - CISMeF

Preferred Label : NVX-CoV2373;

Definition : NVX-CoV2373 is a full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine. Haute Autorité de Santé. Strategie de vaccination contre le SARS-CoV-2.. (Retrieved 08/12/2020, from https://www.has-sante.fr/ );

Synonyme : SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine; Full length recombinant SARS CoV-2 gly-coprotein nanoparticle vaccine;

Details

Origin ID

BGVB935B-4;

Currated CISMeF NLP mapping
- NVX-CoV2373 adjuvated lipid nanoparticle [MeSH Supplementary Concept]
- NVX-CoV2373 adjuvated lipid nanoparticle [MeSH concept]
- SARS-CoV-2 rS Nanoparticle Vaccine NVX-CoV2373 [NCIt concept]
- SARS-CoV-2 recombinant spike protein NOS [SMS substance]
Related concepts
- Matrix-M™ [COVID-19 Thesaurus concept]
- Novavax [COVID-19 Thesaurus concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients